Loading clinical trials...

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis | Clinical Trials | Clareo Health

COMPLETEDNA

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

A Randomized, Single-Blind, Active Control, 18-Week Study to Evaluate the Safety and Efficacy of A New Twice-Daily, Topically Applied LCD Solution vs. Calcipotriol Cream for the Treatment of Adult Subjects With Moderate Plaque Psoriasis

NCT00705900•NeoStrata Company, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare the safety and effectiveness of a new topical LCD solution and a commercially available calcipotriol (Vitamin D) cream in reducing the symptoms of plaque psoriasis and improving the quality of life in adults.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•18 years of age or older
•able and willing to provide written informed consent
•diagnosed with chronic plaque psoriasis
•3% to 15% body surface area involved
•in good general health

Exclusion Criteria

•other current treatments for psoriasis
•renal or liver dysfunction
•pregnant or nursing

Locations (1)

Mass General Hospital: Clinical Unit for Research Trials in Skin

Boston, Massachusetts, United States

Key Dates

Start Date

January 1, 2007

Primary Completion Date

November 1, 2008

Completion Date

November 1, 2008

Last Updated

November 19, 2008

Enrollment

ESTIMATED participants

Conditions

Chronic Plaque Psoriasis

Interventions

LCD

DRUG

calcipotriol

DRUG

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03598790

Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis

View study

COMPLETEDPHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03370133

Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2008Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Safety and Tolerability of Repeat Courses of IM Alefacept

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis